Stoke Therapeutics (STOK) Asset Utilization Ratio (2022 - 2026)

Stoke Therapeutics' Asset Utilization Ratio history runs 5 years deep, the most recent figure standing at 0.07 for Q1 2026.

• In Q1 2026, Asset Utilization Ratio fell 86.77% year-over-year to 0.07; the TTM figure through Mar 2026 stood at 0.07 (down 86.77% YoY), while the FY2025 annual figure was 0.53, up 265.51% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.07, down from 0.47 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.56 in Q1 2025, with the low at 0.05 in Q4 2022.
• The 5-year median for Asset Utilization Ratio is 0.06 (2024), against an average of 0.2.
• The sharpest annual moves came in 2025 and 2026: Asset Utilization Ratio jumped 891.2% in 2025, then slumped 86.77% in 2026.
• Stoke Therapeutics' Asset Utilization Ratio stood at 0.05 in 2022, then climbed by 26.28% to 0.06 in 2023, then surged by 120.48% to 0.13 in 2024, then surged by 265.97% to 0.47 in 2025, then sank by 84.28% to 0.07 in 2026.
• Business Quant data shows STOK's Asset Utilization Ratio at 0.07 in Q1 2026, 0.47 in Q4 2025, and 0.55 in Q3 2025.